# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Amplify Bio to complete GLP study of SPC-15 Novel Intranasal TherapeuticSilo study advances SPC-15 towards first-in-human trial
Silo Pharma shares are trading lower by 31% during Wednesday's session. The company announced it has entered into agreement...